Product Information
DILTIAZEM 12HR ER 120 MG CAP is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $1.9704 per EA under NDC 75907004601. Its NADAC has been published 88 times since Jan 29, 2025.
FDA first approved this application on May 5, 2022. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
120 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
75907004601
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215775FDA Approved
5/5/2022
TE Code
AB1
On Market Since
9/10/2024
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 12HR ER 120 MG CAP has been published 88 times since Jan 29, 2025, and over the history we have for it it has declined 4.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9704 per EA |
|---|---|
| All-time high | $2.5115 (Sep 10, 2025) |
| All-time low | $1.9704 (Sep 23, 2026) |
| 52-week high | $2.4718 |
| 52-week low | $1.9704 |
| Median price | $2.3070 |
| Average price | $2.2960 |
| Largest weekly change | +14.8% (Feb 19, 2025) |
| Weeks tracked | 88 |
| Tracking since | Jan 29, 2025 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diltiazem Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DILTIAZEM 12HR ER 120 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 12HR ER 120 MG CAP, manufactured by Dr. Reddy's Laboratories Inc., is $1.9704 per EA (NDC 75907004601), effective Sep 30, 2026.
How has the price of DILTIAZEM 12HR ER 120 MG CAP changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 12HR ER 120 MG CAP has declined 4.6%. It has been tracked across 88 weekly CMS publications since Jan 29, 2025.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 12HR ER 120 MG CAP?
Since Jan 29, 2025, the NADAC for DILTIAZEM 12HR ER 120 MG CAP has ranged from a low of $1.9704 (Sep 23, 2026) to a high of $2.5115 (Sep 10, 2025), with a median of $2.3070 per EA.
Are there cheaper alternatives to DILTIAZEM 12HR ER 120 MG CAP?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 24HR ER 120 MG CAP, is $0.0903 per EA — about 95% below DILTIAZEM 12HR ER 120 MG CAP.
Who manufactures DILTIAZEM 12HR ER 120 MG CAP?
DILTIAZEM 12HR ER 120 MG CAP (NDC 75907004601) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.